Curaegis Technologies Inc (OTCMKTS:CRGS) shares are up 22.42% on Friday to $1.01 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.26 to $1.11.
Last month, Curaegis Technologies Inc CEO Richard Kaplan provided an update on the company’s events and accomplishments. First off, he announced that they appointed James R. Donnelly as Senior Vice President of Sales & Marketing. As such, he will be responsible for creating sales and marketing plans, sales processes and supporting the sales vice presidents in each of our identified vertical market opportunities.
“We are very excited about working with Jim. His abilities and experience match up perfectly to implement and accelerate our sales initiatives,” Kaplan remarked.
He also mentioned that Curaegis Technologies Inc added two important and prestigious members to their Scientific Advisory Board: Dr. Michael Grandner from the Sleep and Health Research Program at the University of Arizona and Dr. Torbjorn Akerstedt from the Stress Research Institute at Stockholm University in Sweden.
Dr. Grandner’s research focuses on how sleep and sleep-related behaviors are related to cardiovascular disease, diabetes, obesity, neurocognitive functioning, mental health, and longevity while Dr. Akerstedt is one of the most preeminent researchers in the area of fatigue management in the world, having developed one of the gold standard tests called the KSS Test for sleep and fatigue analysis.
“I believe that Dr. Akerstedt will be instrumental as we expand to international markets. Dr. Grandner and Dr. Akerstedt are highly respected experts in the field of Fatigue and Sleep Management and we are very proud and excited for them to join our Scientific Advisory Board,” said Kaplan.
Lastly, he mentioned that they have extended their internal beta testing to allow for further software refinement and anticipates the launch of their external beta phase this month.
Curaegis Technologies Inc is a company that develops and markets technologies in the areas of power, safety and wellness. In particular, it is focused on technologies, such as the Circadian User Risk Assessment (CURA) system and the Aegis hydraulic pump.
The company’s divisions include CURA Division and Aegis Division. The CURA division is engaged in the fatigue management business. The CURA system consists of individual elements, including the myCadian watch, panic-button and man-down system, CURA software, and the Z-Coach wellness program. The myCadian watch is a wearable device paired with the CURA system that provides real-time alertness and emergency monitoring system that addresses sleep and fatigue management solutions. The Z-Coach e-learning module includes Z-Coach Aviation, which is designed for aviation professionals, from flight and ground crews, to scheduling, dispatch, administration and management. The Aegis division is engaged in the power and hydraulic business.